Blood-based biomarker may redefine the future treatment for advanced melanoma
Measuring circulating tumor DNA may lead to alternative treatment options and better outcomes for patients with advanced BRAF-negative melanoma, report investigators in The Journal of Molecular Diagnostics
Prediction of the risk of recurrence of venous thrombosis – validity of the Vienna Prediction Model confirmed
A prediction model can be used to identify people affected by venous thromboembolism who have only a low risk of recurrence and may not require long-term blood thinning….
Use of Antiviral Medication Shown To Preserve Insulin Production In Children Newly Diagnosed With Type 1 Diabetes
Norwegian researchers have previously demonstrated an association between diabetes and virus infection.
Possible new treatment for Acute myeloid leukemia (AML)
New research has identified a novel immunotherapy for acute myeloid leukemia. The study, published in Nature Cancer, describes a T-cell receptor that recognizes a mutation shared between a…
Breakthrough in the fight against resistance in metastatic breast cancer
A team of researchers at the Medical University of Vienna has discovered that dormant tumor cells surviving chemotherapy can be targeted through the inhibition of a specific protein…